177 related articles for article (PubMed ID: 30674344)
1. Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer.
Kashyap VK; Wang Q; Setua S; Nagesh PKB; Chauhan N; Kumari S; Chowdhury P; Miller DD; Yallapu MM; Li W; Jaggi M; Hafeez BB; Chauhan SC
J Exp Clin Cancer Res; 2019 Jan; 38(1):29. PubMed ID: 30674344
[TBL] [Abstract][Full Text] [Related]
2. Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer.
Mahmud F; Deng S; Chen H; Miller DD; Li W
Cancer Lett; 2020 Dec; 495():76-88. PubMed ID: 32920198
[TBL] [Abstract][Full Text] [Related]
3. βIII-tubulin: a novel mediator of chemoresistance and metastases in pancreatic cancer.
McCarroll JA; Sharbeen G; Liu J; Youkhana J; Goldstein D; McCarthy N; Limbri LF; Dischl D; Ceyhan GO; Erkan M; Johns AL; Biankin AV; Kavallaris M; Phillips PA
Oncotarget; 2015 Feb; 6(4):2235-49. PubMed ID: 25544769
[TBL] [Abstract][Full Text] [Related]
4. An Orally Available Tubulin Inhibitor, VERU-111, Suppresses Triple-Negative Breast Cancer Tumor Growth and Metastasis and Bypasses Taxane Resistance.
Deng S; Krutilina RI; Wang Q; Lin Z; Parke DN; Playa HC; Chen H; Miller DD; Seagroves TN; Li W
Mol Cancer Ther; 2020 Feb; 19(2):348-363. PubMed ID: 31645441
[TBL] [Abstract][Full Text] [Related]
5. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
[TBL] [Abstract][Full Text] [Related]
6. Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity.
Guzmán EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE
Int J Cancer; 2016 Nov; 139(9):2116-26. PubMed ID: 27376928
[TBL] [Abstract][Full Text] [Related]
7. VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway.
Kashyap VK; Dan N; Chauhan N; Wang Q; Setua S; Nagesh PKB; Malik S; Batra V; Yallapu MM; Miller DD; Li W; Hafeez BB; Jaggi M; Chauhan SC
Cancer Lett; 2020 Feb; 470():64-74. PubMed ID: 31809801
[TBL] [Abstract][Full Text] [Related]
8. Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids.
Sharbeen G; McCarroll J; Liu J; Youkhana J; Limbri LF; Biankin AV; Johns A; Kavallaris M; Goldstein D; Phillips PA
Neoplasia; 2016 Dec; 18(12):753-764. PubMed ID: 27889644
[TBL] [Abstract][Full Text] [Related]
9. [Down-regulated βIII-tubulin expression can reverse paclitaxel resistance in A549/taxol cells lines].
Zhuo Y; Guo Q
Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):581-7. PubMed ID: 25130963
[TBL] [Abstract][Full Text] [Related]
10. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
[TBL] [Abstract][Full Text] [Related]
11. Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment.
Massey AE; Sikander M; Chauhan N; Kumari S; Setua S; Shetty AB; Mandil H; Kashyap VK; Khan S; Jaggi M; Yallapu MM; Hafeez BB; Chauhan SC
Nanomedicine; 2019 Aug; 20():102027. PubMed ID: 31170509
[TBL] [Abstract][Full Text] [Related]
12. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
[TBL] [Abstract][Full Text] [Related]
13. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.
Vetter NS; Kolb EA; Mills CC; Sampson VB
Mol Cancer Res; 2017 Jul; 15(7):953-964. PubMed ID: 28275089
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer.
Wang W; Zhang H; Wang X; Patterson J; Winter P; Graham K; Ghosh S; Lee JC; Katsetos CD; Mackey JR; Tuszynski JA; Wong GK; Ludueña RF
Protoplasma; 2017 May; 254(3):1163-1173. PubMed ID: 27943021
[TBL] [Abstract][Full Text] [Related]
15. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
Cai P; Lu P; Sharom FJ; Fang WS
Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
[TBL] [Abstract][Full Text] [Related]
16. Identification of betaIII- and betaIV-tubulin isotypes in cold-adapted microtubules from Atlantic cod (Gadus morhua): antibody mapping and cDNA sequencing.
Modig C; Olsson PE; Barasoain I; de Ines C; Andreu JM; Roach MC; Ludueña RF; Wallin M
Cell Motil Cytoskeleton; 1999; 42(4):315-30. PubMed ID: 10223637
[TBL] [Abstract][Full Text] [Related]
17. Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer).
Sikander M; Malik S; Khan S; Kumari S; Chauhan N; Khan P; Halaweish FT; Chauhan B; Yallapu MM; Jaggi M; Chauhan SC
Cells; 2019 Dec; 9(1):. PubMed ID: 31906106
[TBL] [Abstract][Full Text] [Related]
18. Structural Modification of the 3,4,5-Trimethoxyphenyl Moiety in the Tubulin Inhibitor VERU-111 Leads to Improved Antiproliferative Activities.
Wang Q; Arnst KE; Wang Y; Kumar G; Ma D; Chen H; Wu Z; Yang J; White SW; Miller DD; Li W
J Med Chem; 2018 Sep; 61(17):7877-7891. PubMed ID: 30122035
[TBL] [Abstract][Full Text] [Related]
19. A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer.
Ahn S; Hwang DJ; Barrett CM; Yang J; Duke CB; Miller DD; Dalton JT
Cancer Chemother Pharmacol; 2011 Feb; 67(2):293-304. PubMed ID: 20383708
[TBL] [Abstract][Full Text] [Related]
20. A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer cells.
Kumar A; Singh B; Mahajan G; Sharma PR; Bharate SB; Mintoo MJ; Mondhe DM
Tumour Biol; 2016 Oct; 37(10):13121-13136. PubMed ID: 27449046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
